RNF43 and neoplasm: The whole-exome sequencing data revealed that the somatic gene RNF43, encoding a tumor suppressor targeting the WNT pathway, is mutated in 18-27% of endometrioid ECs.65,66 Most of those genetic alterations are frameshift mutations, which are predicted to cause loss of function of RNF43 on suppressing the tumorigenicity of EC.